Aterian, Inc. filings document material events for a public consumer products company with a portfolio of e-commerce brands and online retail channels. Recent Form 8-K disclosures cover operating results, Regulation FD updates, credit agreement amendments, liquidity covenants, availability reserves, exhibits to material definitive agreements and other capital-structure matters.
The filing record also includes governance and shareholder-vote disclosures, including annual meeting matters, advisory vote frequency decisions, executive compensation voting procedures and officer transition reporting. These filings frame Aterian’s formal disclosures around financial performance, financing arrangements, board and stockholder actions, and corporate strategy updates.
Aterian, Inc. director William Kurtz acquired 150,602 shares of restricted common stock on September 25, 2026, as a grant under the company’s 2018 Equity Incentive Plan. The shares are subject to vesting. His reported direct holdings following the award were 306,524 shares.
Aterian, Inc. says David E. Lazar, its Chief Executive Officer and Interim Chief Financial Officer, sold his interests and rights in 706,100 Series AA and 1,750,000 Series AAA preferred shares to purchasers for $12,000,000 on September 25, 2026. Immediately before the sale, the preferred shares were converted into 241,861,970 common shares. Lazar held approximately 3.1% of outstanding common stock afterward and may no longer be deemed to control Aterian. No purchaser held more than 9.99% of fully diluted common stock outstanding; Aterian said it did not believe any person or group acquired control.
Director Avraham Ben-Tzvi resigned effective September 25, 2026, and William H. Crampton joined the Board and its Audit and Compensation Committees. Crampton received a 301,205-share restricted stock award vesting over three years, subject to continued director service. The Compensation Committee approved a $150,000 retention bonus for Lazar tied to his continued leadership through the filing of Aterian’s Form 10-Q for the quarter ended September 30, 2026.
Aterian also announced an approximately $0.9936-per-CVR cash payment on or about October 2, 2026, subject to required tax withholding. The distribution relates to the July 17, 2026 asset sale to Trademark Global, LLC and Second SPA Closing, identified as Proceeds Events.
Aterian, Inc. (ATER) reported that Chief Executive Officer and ten percent owner David E. Lazar made several preferred-stock transactions. On July 17, 2026, he acquired 1,750,000 Series AAA Convertible Non-Redeemable Preferred Shares at $2.00 per share, for an aggregate $3,500,000, under an April 27, 2026 Securities Purchase Agreement; each share is convertible, after required stockholder approvals, into 135.1 shares of common stock (up to 236,425,000 common shares) at a conversion price of $0.0148 with no additional consideration and no expiration. Following stockholder approval, on August 4, 2026 he converted Series AA Convertible Non-Redeemable Preferred Stock into 6,737,500 shares of common stock and held 6,737,500 common shares directly afterward. The filing states that these transactions were not made under a Rule 10b5-1 trading plan.
Aterian, Inc. (ATER) discloses that David Elliot Lazar has become its controlling stockholder through a $7.0 million investment in newly created preferred stock. Lazar now beneficially owns 249,900,000 shares of common stock equivalent, representing 95.7% of the outstanding common stock on an as-converted basis.
The ownership arises from a Securities Purchase Agreement under which Lazar bought 1,750,000 Series AA and 1,750,000 Series AAA Convertible Non-Redeemable Preferred shares, together convertible into 249,900,000 common shares. On August 4, 2026, he converted 875,000 Series AA shares into 6,737,500 common shares and retained 875,000 Series AA and all 1,750,000 Series AAA shares.
Lazar is now Chief Executive Officer and Chairperson of the Board and has the right to designate and recommend multiple directors. The preferred stock ranks senior to common in liquidation with at least $2.00 per preferred share, has anti-dilution protections, and typically no general voting rights, but requires majority preferred consent for adverse changes. Lazar states he may pursue further securities transactions and strategic deals, including a potential acquisition of an operating business.
Aterian, Inc. reported very limited continuing operations for the quarter ended June 30, 2026 while preparing for a transformational asset and equity transaction that closed in July. Continuing net revenue was only $7 thousand for the quarter and $25 thousand for the first half of 2026, compared with $88 thousand and $151 thousand in the prior-year periods. Loss from continuing operations was $3.96 million for the quarter and $7.40 million year-to-date, similar to 2025. After income from discontinued operations tied to brands being sold, the company posted a quarterly net loss of $0.49 million and a six‑month net loss of $6.62 million.
As of June 30, 2026, Aterian held $2.55 million in cash and $23.53 million in total assets, including $18.18 million classified as held for sale related to marquee brands being sold to Trademark Global for $18.0 million in cash. The company also completed a preferred stock financing with $7.0 million in aggregate proceeds from investor David E. Lazar, who subsequently became CEO and beneficial owner of about 95.8% of voting securities. Management disclosed that, despite debt repayment and cost reductions, the small scale of the remaining legacy brands and ongoing macro pressures continue to raise substantial doubt about Aterian’s ability to continue as a going concern over the next year.
Aterian, Inc. director Ben-Tzvi Avraham filed an initial statement of beneficial ownership showing he holds 0.0000 shares of the company’s Common Stock. A bound footnote clarifies that no shares of Common Stock are beneficially owned.
Aterian, Inc. director Natan David has filed an initial beneficial ownership report indicating that he does not beneficially own any shares of Aterian common stock. The report lists a holding entry for Common Stock with 0.0000 shares beneficially owned, as confirmed by the attached footnote.
Aterian, Inc. is registering for resale up to 6,737,500 shares of Common Stock issuable upon conversion of 875,000 shares of Series AA Convertible Non-Redeemable Preferred Stock, each convertible into 7.7 Common shares. These are being registered for selling stockholder David Lazar and related permitted transferees; Aterian will not receive proceeds from any resale. The registration follows an April 2026 private placement in which Lazar purchased 1,750,000 Series AA and 1,750,000 Series AAA Preferred shares for $7.0 million total, and an $18 million Asset Sale of marquee brands to Trademark Global, LLC. As of July 17, 2026, 10,879,410 Common shares were outstanding. Full conversion of all preferred series would give Lazar very high ownership and voting power, potentially making Aterian a controlled company and causing substantial dilution to existing holders. The company discloses continued operating losses, a recent going-concern paragraph from its auditor, and substantial doubt about its ability to continue as a going concern.